RE:RE:COVID ... BioPUB ...Doccole wrote: Finally saw BioPub. Good direction. H2s was surprising. January/February sounds like a uplisting.
Going to add more, sell some when it doubles from here and ride out the balance until completion or major partnership.
I'm waiting for a billion in cash, and a market cap of 200m, lol. Ready 21
I see ATE getting back into negotiations after Christmas and that continues until they are done - whenever that may be.
I see the comprehensive corporate update just before J.P.Morgan ... around January 10th.
Going into J.P.Morgan, we start seeing some bigger buying activity, as the corporate update excites institutions.
Then we are heavy into Phase 3 countdown, with End-of-Phase2 meeting and the NDA filing.
This brings excitement along with investors piling in.
It is during this time that ATE monitors the share price and decided the right moment to jump to a US exchange. The price has to be right ... or no jump.
I think we're all betting on there being a jump.
The key - the glue - will be the quality of the information, including the comprehensive corporate update. Will it excite? Then there's the matter of the animal studies and how/if those results start to trickle out - maybe it only comes out in the corporate update ??? Will see.
Lots of unknowns but many ways to excite investors.